Related Experiment Video
Updated: Aug 15, 2026

An “All-laser” Endothelial Transplant
Published on: July 6, 2015
The treatment of foveal central serous choroidopathy by krypton red laser
D Weinberger1, I Kremer, I Ben Sira
1Dept. of Ophthalmology, Beilinson Medical Center, Petah Tiqva, Israel.
Abstract:
We present 24 patients with recent foveal central serous choroidopathy. Only those in whom the leakage site was located within a radius of 250 microns from the foveal center were included in this study. All patients were treated with the krypton red laser (647 nm) within a week of the clinical diagnosis. At the end of the follow-up, 70.8% of the patients had a visual acuity of 6/8.5 or better, and an overall visual improvement was found in 83.3%. In 90% of the patients whose vision improved, significant absorption of subretinal fluid was seen within three weeks and in 10% within four weeks. No evidence of any macular pathology complicating the laser treatment was found at the end of the follow-up period of at least 36 months.

